Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer

Abstract Background Circulating tumor cells (CTCs) are linked to metastatic relapse and are regarded as a prognostic marker for human cancer. High expression of plakoglobin, a cell adhesion protein, within the primary tumor is positively associated with CTC clusters in breast cancer. In this study,...

Full description

Bibliographic Details
Main Authors: Wataru Goto, Shinichiro Kashiwagi, Yuka Asano, Koji Takada, Katsuyuki Takahashi, Takaharu Hatano, Tsutomu Takashima, Shuhei Tomita, Hisashi Motomura, Masahiko Ohsawa, Kosei Hirakawa, Masaichi Ohira
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Biomarker Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40364-017-0099-2
_version_ 1828942736937451520
author Wataru Goto
Shinichiro Kashiwagi
Yuka Asano
Koji Takada
Katsuyuki Takahashi
Takaharu Hatano
Tsutomu Takashima
Shuhei Tomita
Hisashi Motomura
Masahiko Ohsawa
Kosei Hirakawa
Masaichi Ohira
author_facet Wataru Goto
Shinichiro Kashiwagi
Yuka Asano
Koji Takada
Katsuyuki Takahashi
Takaharu Hatano
Tsutomu Takashima
Shuhei Tomita
Hisashi Motomura
Masahiko Ohsawa
Kosei Hirakawa
Masaichi Ohira
author_sort Wataru Goto
collection DOAJ
description Abstract Background Circulating tumor cells (CTCs) are linked to metastatic relapse and are regarded as a prognostic marker for human cancer. High expression of plakoglobin, a cell adhesion protein, within the primary tumor is positively associated with CTC clusters in breast cancer. In this study, we investigated the correlation between plakoglobin expression and survival of breast cancer. Methods We evaluated 121 breast cancer patients treated with neoadjuvant chemotherapy. Expression of plakoglobin was identified by immunohistochemical staining in the cell membrane. We also examined the relation between the expression of plakoglobin and E-cadherin, an epithelial–mesenchymal transition (EMT) marker. Results Patients with high plakoglobin expression had significantly worse distant-metastasis-free survival (DMFS) (P = 0.016, log rank). Plakoglobin expression had no correlation with pathological complete response rate (P = 0.627). On univariate analysis with respect to distant metastasis, high plakoglobin expression showed worse prognosis than low plakoglobin expression [P = 0.036, hazard ratio (HR) = 3.719]. Multivariate analysis found the same result (P = 0.013, HR = 5.052). In addition, there was a significant relationship between the expression of plakoglobin and E-cadherin (P = 0.023). Conclusions Plakoglobin expression is an independent prognostic factor in patients with breast cancer, particularly for DMFS, and this is related to EMT.
first_indexed 2024-12-14T04:01:43Z
format Article
id doaj.art-84c8976f808b47138b07f66e496e27df
institution Directory Open Access Journal
issn 2050-7771
language English
last_indexed 2024-12-14T04:01:43Z
publishDate 2017-05-01
publisher BMC
record_format Article
series Biomarker Research
spelling doaj.art-84c8976f808b47138b07f66e496e27df2022-12-21T23:17:56ZengBMCBiomarker Research2050-77712017-05-01511810.1186/s40364-017-0099-2Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancerWataru Goto0Shinichiro Kashiwagi1Yuka Asano2Koji Takada3Katsuyuki Takahashi4Takaharu Hatano5Tsutomu Takashima6Shuhei Tomita7Hisashi Motomura8Masahiko Ohsawa9Kosei Hirakawa10Masaichi Ohira11Department of Surgical Oncology, Osaka City University Graduate School of MedicineDepartment of Surgical Oncology, Osaka City University Graduate School of MedicineDepartment of Surgical Oncology, Osaka City University Graduate School of MedicineDepartment of Surgical Oncology, Osaka City University Graduate School of MedicineDepartment of Pharmacology, Osaka City University Graduate School of MedicineDepartment of Plastic and Reconstructive Surgery, Osaka City University Graduate School of MedicineDepartment of Surgical Oncology, Osaka City University Graduate School of MedicineDepartment of Pharmacology, Osaka City University Graduate School of MedicineDepartment of Plastic and Reconstructive Surgery, Osaka City University Graduate School of MedicineDepartment of Diagnostic Pathology, Osaka City University Graduate School of MedicineDepartment of Surgical Oncology, Osaka City University Graduate School of MedicineDepartment of Surgical Oncology, Osaka City University Graduate School of MedicineAbstract Background Circulating tumor cells (CTCs) are linked to metastatic relapse and are regarded as a prognostic marker for human cancer. High expression of plakoglobin, a cell adhesion protein, within the primary tumor is positively associated with CTC clusters in breast cancer. In this study, we investigated the correlation between plakoglobin expression and survival of breast cancer. Methods We evaluated 121 breast cancer patients treated with neoadjuvant chemotherapy. Expression of plakoglobin was identified by immunohistochemical staining in the cell membrane. We also examined the relation between the expression of plakoglobin and E-cadherin, an epithelial–mesenchymal transition (EMT) marker. Results Patients with high plakoglobin expression had significantly worse distant-metastasis-free survival (DMFS) (P = 0.016, log rank). Plakoglobin expression had no correlation with pathological complete response rate (P = 0.627). On univariate analysis with respect to distant metastasis, high plakoglobin expression showed worse prognosis than low plakoglobin expression [P = 0.036, hazard ratio (HR) = 3.719]. Multivariate analysis found the same result (P = 0.013, HR = 5.052). In addition, there was a significant relationship between the expression of plakoglobin and E-cadherin (P = 0.023). Conclusions Plakoglobin expression is an independent prognostic factor in patients with breast cancer, particularly for DMFS, and this is related to EMT.http://link.springer.com/article/10.1186/s40364-017-0099-2PlakoglobinCirculating tumor cellsNeoadjuvant chemotherapyBreast cancerPredictive marker
spellingShingle Wataru Goto
Shinichiro Kashiwagi
Yuka Asano
Koji Takada
Katsuyuki Takahashi
Takaharu Hatano
Tsutomu Takashima
Shuhei Tomita
Hisashi Motomura
Masahiko Ohsawa
Kosei Hirakawa
Masaichi Ohira
Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
Biomarker Research
Plakoglobin
Circulating tumor cells
Neoadjuvant chemotherapy
Breast cancer
Predictive marker
title Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
title_full Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
title_fullStr Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
title_full_unstemmed Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
title_short Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
title_sort circulating tumor cell clusters associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
topic Plakoglobin
Circulating tumor cells
Neoadjuvant chemotherapy
Breast cancer
Predictive marker
url http://link.springer.com/article/10.1186/s40364-017-0099-2
work_keys_str_mv AT watarugoto circulatingtumorcellclustersassociatedgeneplakoglobinisasignificantprognosticpredictorinpatientswithbreastcancer
AT shinichirokashiwagi circulatingtumorcellclustersassociatedgeneplakoglobinisasignificantprognosticpredictorinpatientswithbreastcancer
AT yukaasano circulatingtumorcellclustersassociatedgeneplakoglobinisasignificantprognosticpredictorinpatientswithbreastcancer
AT kojitakada circulatingtumorcellclustersassociatedgeneplakoglobinisasignificantprognosticpredictorinpatientswithbreastcancer
AT katsuyukitakahashi circulatingtumorcellclustersassociatedgeneplakoglobinisasignificantprognosticpredictorinpatientswithbreastcancer
AT takaharuhatano circulatingtumorcellclustersassociatedgeneplakoglobinisasignificantprognosticpredictorinpatientswithbreastcancer
AT tsutomutakashima circulatingtumorcellclustersassociatedgeneplakoglobinisasignificantprognosticpredictorinpatientswithbreastcancer
AT shuheitomita circulatingtumorcellclustersassociatedgeneplakoglobinisasignificantprognosticpredictorinpatientswithbreastcancer
AT hisashimotomura circulatingtumorcellclustersassociatedgeneplakoglobinisasignificantprognosticpredictorinpatientswithbreastcancer
AT masahikoohsawa circulatingtumorcellclustersassociatedgeneplakoglobinisasignificantprognosticpredictorinpatientswithbreastcancer
AT koseihirakawa circulatingtumorcellclustersassociatedgeneplakoglobinisasignificantprognosticpredictorinpatientswithbreastcancer
AT masaichiohira circulatingtumorcellclustersassociatedgeneplakoglobinisasignificantprognosticpredictorinpatientswithbreastcancer